Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of S-600918 on the Pharmacokinetics of Fexofenadine, Rosuvastatin, and Atorvastatin in Healthy Adults
jRCT2080224683Phase 1Completed
- Sponsor
- Shionogi & Co., Ltd.
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, single-arm trial of sivopixant in cough, sponsored by Shionogi & Co., Ltd. Primary endpoint: Primary pharmacokinetic endpoints. Started May 2019; status: completed.
02
Drugs
sivopixant
03
Conditions
cough
Beyond the preview
Go deeper on jRCT2080224683.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224683.